Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery

被引:18
作者
Horlick, RA
Sperle, K
Breth, LA
Reid, CC
Shen, ES
Robbins, AK
Cooke, GM
Largent, BL
机构
[1] DUPONT MERCK PHARMACEUT CO, EXPT STN, APPL BIOTECHNOL DEPT, WILMINGTON, DE 19880 USA
[2] DUPONT MERCK PHARMACEUT CO, EXPT STN, CENT NERVOUS SYST DIS RES DEPT, WILMINGTON, DE 19880 USA
[3] WYETH AYERST RES, WOMENS HLTH RES INST, RADNOR, PA 19087 USA
关键词
D O I
10.1006/prep.1996.0701
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human HEK293 cells that stably express the Epstein Barr nuclear antigen 1 (EBNA1) support the episomal replication of plasmids containing the Epstein Barr virus origin of replication (EBV oriP). A 293EBNA (293E) cell line expressing the human corticotropin-releasing hormone receptor subtype I (CRHR1) from an episomal plasmid was generated (293CR1s), analyzed, adapted to spinner culture, and scaled-up for production in less than 6 weeks, Forty-seven stable CHO cell lines transfected with CRHR1 were also isolated. Expression of the receptor in the best of these lines (as judged by CRH-induced cAMP production), CHO-R22, was compared to that in 293CR1s cells. Results indicate that the CRHR1 episomal expression vector in 293E cells (1) rapidly generates stable cell lines suitable for scale-up; (2) is stably maintained during 3 months in culture; (3) expresses high levels of CRHR1 mRNA; and (4) expresses significantly more CRHR1 than the CHO-R22 line. Coexpression of additional G protein alpha subunit (G(alpha s)) with CRHR1 in 293E cells converts a higher percentage of receptor to the agonist high-affinity G-protein-coupled state. Our data support the idea that using the EBV oriP-driven episomal system for gene expression results in greater production of protein in a relatively short period of time. (C) 1997 Academic Press.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 25 条
[1]  
ADHAM N, 1993, MOL PHARMACOL, V43, P427
[2]   EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR [J].
CHEN, RP ;
LEWIS, KA ;
PERRIN, MH ;
VALE, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8967-8971
[3]   THE USE OF ENGINEERED E1A GENES TO TRANSACTIVATE THE HCMV-MIE PROMOTER IN PERMANENT CHO CELL-LINES [J].
COCKETT, MI ;
BEBBINGTON, CR ;
YARRANTON, GT .
NUCLEIC ACIDS RESEARCH, 1991, 19 (02) :319-325
[4]  
De Souza Errol B., 1995, P505
[5]   THE HUMAN CYTOMEGALO-VIRUS MAJOR IMMEDIATE EARLY PROMOTER CAN BE TRANS-ACTIVATED BY ADENOVIRUS EARLY PROTEINS [J].
GORMAN, CM ;
GIES, D ;
MCCRAY, G ;
HUANG, M .
VIROLOGY, 1989, 171 (02) :377-385
[6]   CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[7]  
HAY R, 1992, ATCC CATALOGUE CELL, P148
[8]  
HOGAN B, 1986, MANIPULATING MOUSE E, P174
[9]   AN EBV-BASED MAMMALIAN-CELL EXPRESSION VECTOR FOR EFFICIENT EXPRESSION OF CLONED CODING SEQUENCES [J].
JALANKO, A ;
KALLIO, A ;
RUOHONENLEHTO, M ;
SODERLUND, H ;
ULMANEN, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 949 (02) :206-212
[10]  
JAMES MR, 1989, MUTAT RES, V202, P169